Valuation: BioGaia AB

Market Cap 11.68B 1.22B 1.06B 991M 910M 1.72B 116B 1.75B 4.58B 58.05B 4.59B 4.49B 191B P/E 2026 *
30.2x
P/E 2027 * 24.6x
Enterprise Value 11.02B 1.15B 1B 934M 858M 1.62B 110B 1.65B 4.31B 54.74B 4.33B 4.23B 181B EV / Sales 2026 *
6.6x
EV / Sales 2027 * 5.88x
Free-Float
80.82%
Yield 2026 *
2.55%
Yield 2027 * 2.77%
1 day-0.13%
1 week-0.09%
Current month-0.09%
1 month-5.33%
3 months-2.70%
6 months+5.58%
Current year+8.76%
1 week 113.8
Extreme 113.8
117
1 month 113.8
Extreme 113.8
128.4
Current year 97.5
Extreme 97.5
136.3
1 year 93.2
Extreme 93.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.6
Extreme 48.6
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%-0.09%+21.01%+8.25% 1.23B
-0.44%+13.80%+32.84%-1.58% 76.15B
-0.67%-10.00%+19.77%+174.96% 48.89B
-4.18%+42.30%+42.30%+42.30% 47.83B
+1.01%+8.83%-52.93%-53.63% 41.37B
-0.56%+0.84%+52.66%-24.62% 29.99B
-0.91%-0.37%+51.76%+82.26% 24.23B
+0.58%-0.88%+99.49%-49.85% 21.89B
-0.81%-4.39%-7.53%+165.02% 19.25B
-7.35%-4.68%+64.90%+111.65% 17.14B
Average -1.29%+0.91%+32.43%+45.47% 32.79B
Weighted average by Cap. -1.16%+2.35%+28.37%+41.17%

Financials

2026 *2027 *
Net sales 1.67B 174M 152M 142M 130M 245M 16.63B 249M 654M 8.29B 655M 641M 27.36B 1.88B 196M 170M 159M 146M 275M 18.69B 280M 735M 9.32B 737M 720M 30.75B
Net income 387M 40.45M 35.15M 32.82M 30.13M 56.81M 3.86B 57.8M 152M 1.92B 152M 149M 6.34B 474M 49.54M 43.06M 40.2M 36.9M 69.58M 4.72B 70.8M 186M 2.35B 186M 182M 7.77B
Net Debt -667M -69.72M -60.59M -56.57M -51.93M -97.92M -6.65B -99.62M -261M -3.31B -262M -256M -10.93B -646M -67.47M -58.64M -54.74M -50.26M -94.76M -6.43B -96.41M -253M -3.21B -253M -248M -10.58B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
03/08/26 SEK 115.50 -0.09% 78,076
31/07/26 SEK 115.60 -0.17% 74,457
30/07/26 SEK 115.80 +0.26% 71,140
29/07/26 SEK 115.50 +0.17% 96,873
28/07/26 SEK 115.30 -0.95% 127,200
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
115.60SEK
Average target price
152.50SEK
Spread / Average Target
+31.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock